Autoimmune Diseases  >>  methylprednisolone sodium succinate  >>  Phase 4
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
methylprednisolone sodium succinate / Generic mfg.
NCT00462345: A Study of MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-TNF Therapies.

Completed
4
40
RoW
rituximab, MabThera, Rituxan, Methotrexate, Corticosteroid or NSAID, Folate
Hoffmann-La Roche
Rheumatoid Arthritis
07/09
07/09
NCT00753792 / 2007-000888-15: Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse

Completed
4
49
Europe
methylprednisolone, Group A, Group B, Placebo
Germans Trias i Pujol Hospital
Multiple Sclerosis
11/10
01/11
SWITCH, NCT01295151 / 2010-023880-17: Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.

Checkmark P4 data - ACR/ARHP 2012 (SWITCH-RA)
Sep 2012 - Sep 2012: P4 data - ACR/ARHP 2012 (SWITCH-RA)
Completed
4
122
Europe
Etanercept, Abatacept, Rituximab, Adalimumab, Certolizumab Pegol, Infliximab, Golimumab
Julia Brown
Rheumatoid Arthritis
11/15
11/15
NCT02645565: Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis

Completed
4
75
RoW
Cyclophosphamide, Endoxan, Azathioprine, Imuran, Methylprednisolone, prednisolone,steroid
Jawaharlal Institute of Postgraduate Medical Education & Research
Lupus Nephritis
12/16
12/16

Download Options